Nexstim Reaches 208
Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry
20 août 2021 02h00 HE | Nexstim Oyj
Press release, Helsinki, 20 August 2021 at 9 AM (EEST) Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry...
Nexstim Receives a N
Nexstim Receives a New NBS System Order from the Medical University of South Carolina
10 août 2021 03h00 HE | Nexstim Oyj
Press release, Helsinki, 10 August 2021 at 10:00 AM (EEST) Nexstim Receives a New NBS System Order from the Medical University of South Carolina Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
Nexstim to Exhibit a
Nexstim to Exhibit at the Texas Association of Neurological Surgeons Annual Meeting
04 août 2021 09h00 HE | Nexstim Oyj
Press release, Helsinki, 4 August 2021 at 4 PM (EEST) Nexstim to Exhibit at the Texas Association of Neurological Surgeons Annual Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Receives an
Nexstim Receives an NBS System Order from a University Hospital in Germany
29 juil. 2021 03h00 HE | Nexstim Oyj
Press release, Helsinki, 29 July 2021 at 10 AM (EEST) Nexstim Receives an NBS System Order from a University Hospital in Germany Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim Receives an
Nexstim Receives an NBS System Upgrade Order from a University Hospital in Finland
16 juil. 2021 02h00 HE | Nexstim Oyj
Press Release, Helsinki, 16 July 2021 at 9:00 PM (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System upgrade order from a university...
 Nexstim Continues t
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
21 juin 2021 03h30 HE | Nexstim Oyj
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Nexstim Receives an
Nexstim Receives an NBS System Order from Australia
19 mai 2021 05h00 HE | Nexstim Oyj
Press release, Helsinki, 19 May 2021 at 12 PM (EEST) Nexstim Receives an NBS System Order from Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company”) announces having received a...
 Nexstim granted aut
Nexstim granted authorization for commercial distribution of NBS system in Australia
18 mai 2021 03h00 HE | Nexstim Oyj
Press release, Helsinki, 18 May 2021 at 10 AM (EEST) Nexstim granted authorization for commercial distribution of NBS system in Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company”)...
Impressive New Study
Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus® nTMS in Postsurgical Rehabilitation of Paresis
17 mai 2021 03h30 HE | Nexstim Oyj
Press release, Helsinki, 17 May 2021 at 10:30 AM (EEST) Impressive New Study Results Suggest Potential New Therapeutic Use for Nexstim SmartFocus® nTMS in Postsurgical Rehabilitation of Paresis ...
Nexstim Receives a N
Nexstim Receives a New NBS System Order from a Leading California Based Academic Hospital
07 mai 2021 03h00 HE | Nexstim Oyj
Press release, Helsinki, 7.5.2021 at 10:00 AM (EEST) Nexstim Receives a New NBS System Order from a Leading California Based Academic Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...